ClinicalTrials.gov
public full text
Public Domain
MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044)
This study is a double-blind, randomized study of MK0991 versus liposomal amphotericin B in the empirical treatment of pediatric patients (ages 2 through 17 years) who have an absolute neutrophil count (ANC) below 500/microliter and who have fever despite broad antibiotic coverage. Such patients would be candidates for empirical therapy with an intravenous anti-fungal agent.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Curcumin in Pediatric Inflammatory Bowel Disease#854916
- Infliximab Infusion Rates in Pediatric Inflammatory Bowel Disease#1171354
- The role of lipid-derived indices in patients with MASLD in Turkey: a nationwide, multicenter cross-sectional study#315277
- Evaluation of oral manifestations and mandibular bone fractal dimension in pediatric inflammatory bowel disease.#465214
- Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis#886995
Record · ID 918564
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive